First Tracks Biotherapeutics Inc (TRAX)

NASDAQ · Biotechnology

47.10
-1.60 (-3.29%)
Updated Nov 16, 3:47 AM ET
AI Rating
Buy
Overall Score
67
Trend
72
Momentum
88
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Apr 6, 2026 156 sessions Nov 13, 2026

AI Analysis

First Tracks Biotherapeutics Inc is trading at $47.10, down 3.29% on the session. The 50 day average sits at $39.90 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 56.5, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $43.32 with resistance near $47.55, so that band frames the current range. Average daily movement is roughly $3.33, or about 7.1% of the share price, which is what any stop placement has to allow for. The overall health score of 67 out of 100 combines a trend score of 72, momentum of 88 and a risk score of 28.

Technical indicators

RSI (14)
56.5
strong
MACD
2.958
bullish crossover
SMA 20
45.73
SMA 50
39.90
SMA 200
--
unknown
ATR (14)
3.33
avg daily range
Support
43.32
Resistance
47.55
Volume vs 20d
0.64x
below average
Volatility
71.6%
annualised
1 month
+30.69%
3 months
+8.03%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.